Insider trades
Clay B. Siegall, Director of Shattuck Labs STTK, has filed 12 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $2M. The latest trade was on 06/09.
Clay B. Siegall
Director
- Company
- Shattuck Labs STTK
- First filing
- 23/10/04
- Trades
- 29 trades
- Buys / sales
- 12 / 0
- 12-month net buying
- $2M
- Last trade
- 06/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Shattuck LabsSTTK | Open-market buy | 06/09 | 06/11 | 62,500 sh | $4.00 | $250,000 | +24.4% |
ImmunomeIMNM | Open-market buy | 03/27 | 03/31 | 25,450 sh | $19.67 | $500,601.5 | +3.8% |
ImmunomeIMNM | Open-market buy | 25/12/30 | 25/12/30 | 4,729 sh | $21.15 | $100,018.35 | +0.7% |
ImmunomeIMNM | Open-market buy | 25/12/19 | 25/12/22 | 7,278 sh | $20.48 | $149,053.44 | +0.9% |
ImmunomeIMNM | Open-market buy | 25/12/18 | 25/12/18 | 46,511 sh | $21.50 | $999,986.5 | +5.8% |
ImmunomeIMNM | Open-market buy | 25/03/26 | 25/03/26 | 137,100 sh | $7.29 | $999,459 | +20.5% |
ImmunomeIMNM | Open-market buy | 25/01/31 | 25/02/03 | 150,000 sh | $7.75 | $1,162,500 | +28.9% |
| Open-market buy | 24/11/21–24/11/22 | 24/11/25 | 100,000 sh2 trades | $9.62avg. | $962,146.32 | +23.8% | |
| Open-market buy | 24/05/20–24/05/21 | 24/05/21 | 100,000 sh2 trades | $13.88avg. | $1,388,343.58 | +31.3% | |
ImmunomeIMNM | Open-market buy | 23/10/02 | 23/10/04 | 169,204 sh | $5.91 | $999,995.64 | +112.5% |